GSTC Share Price Performance
US$0.000001
-0.00 (-99.75%)
Price US$0.000001
Share PriceUS$0.000001
GSTC Community Narratives
There are no narratives available yet.
Recent GSTC News & Updates
GlobeStar Therapeutics Corporation Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.00074
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -20.2%
GlobeStar Therapeutics Corporation Competitors
Snowflake Analysis
About GSTC
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, offers a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.
Market Insight
This week, we’re going to look at the U.S. regulatory changes, how adoption has been trending, and one of the risks with the ETFs. If you want some exposure to Bitcoin, at the end, we’ll show you some different ways you can position your portfolio accordingly.
Continue reading
U.S. Market Performance
- 7 Days: -1.5%
- 3 Months: 9.5%
- 1 Year: 14.4%
- Year to Date: 8.4%
Over the last 7 days, the market has dropped 1.5%, driven by a pullback of 3.5% in the Information Technology sector. As for the longer term, the market has actually risen by 14% in the last year. Earnings are forecast to grow by 15% annually. Market details ›